Understanding and Interpreting MRI of the Genitourinary Tract

Urologic Clinics of North America

Volumn 33, Issue 3, 2006, Pages 301-317

  Bassignani, Matthew J ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM;

ADRENAL CORTEX ADENOMA; ADRENAL GLAND; ANGIOMYOLIPOMA; CANCER DIAGNOSIS; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; DIAGNOSTIC REASONING; DIAGNOSTIC VALUE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; IONIZING RADIATION; KIDNEY CARCINOMA; KIDNEY CYST; KIDNEY FAILURE; KIDNEY TUMOR; MEDICAL INFORMATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; UROGENITAL SYSTEM; UROGENITAL TRACT DISEASE; UROGRAPHY; VON HIPPEL LINDAU DISEASE;

ADRENAL GLAND DISEASES; FEMALE UROGENITAL DISEASES; HUMANS; KIDNEY DISEASES; MAGNETIC RESONANCE IMAGING; MALE UROGENITAL DISEASES; PHYSICS; UROGRAPHY;

EID: 33745608704     PISSN: 00940143     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ucl.2006.03.008     Document Type: Review

References (34)

1. Farres M.T., Gattegno B., Ronco P., et al. Nonnephrotoxic, dynamic, contrast enhanced magnetic resonance urography: use in nephrology and urology. J Urol 163 4 (Apr 2000) 1191-1196 quiz 1295
2. Probert J.L., Glew D., and Gillatt D.A. Magnetic resonance imaging in urology. BJU Int 83 3 (1999) 201-214
3. Pretorius E.S., Wickstrom M.L., and Siegelman E.S. MR imaging of renal neoplasms. Magn Reson Imaging Clin N Am 8 4 (2000) 813-836
4. Semelka R.C., Hricak H., Stevens S.K., et al. Combined gadolinium-enhanced and fat-saturation MR imaging of renal masses. Radiology 178 3 (1991) 803-809
5. Thomsen H.S., and Bush Jr. W.H. Adverse effects of contrast media: incidence, prevention and management. Drug Saf 19 4 (1998) 313-324
6. Bettmann M.A., Heeren T., Greenfield A., et al. Adverse events with radiographic contrast agents: results of the SCVIR Contrast Agent Registry. Radiology 203 3 (1997) 611-620
7. Rudnick M.R., Berns J.S., Cohen R.M., et al. Contrast media-associated nephrotoxicity. Semin Nephrol 17 1 (1997) 15-26
8. Pretorius E.S., Siegelman E.S., Ramchandani P., et al. Renal neoplasms amenable to partial nephrectomy: MR imaging. Radiology 212 1 (1999) 28-34
9. Kallman D.A., King B.F., Hattery R.R., et al. Renal vein and inferior vena cava tumor thrombus in renal cell carcinoma: CT, US, MRI and venacavography. J Comput Assist Tomogr 16 2 (1992) 240-247
10. Oto A., Herts B.R., Remer E.M., et al. Inferior vena cava tumor thrombus in renal cell carcinoma: staging by MR imaging and impact on surgical treatment. AJR Am J Roentgenol 171 6 (1998) 1619-1624
11. Greenlee R.T., Hill-Harmon M.B., Murray T., et al. Cancer statistics, 2001. CA Cancer J Clin 51 1 (2001) 15-36
12. Hricak H., Thoeni R.F., Carroll P.R., et al. Detection and staging of renal neoplasms: a reassessment of MR imaging. Radiology 166 3 (1988) 643-649
13. Ho V.B., Allen S.F., Hood M.N., et al. Renal masses: quantitative assessment of enhancement with dynamic MR imaging. Radiology 224 3 (2002) 695-700
14. Hartman D.S., Davis Jr. C.J., Johns T., et al. Cystic renal cell carcinoma. Urology 28 2 (1986) 145-153
15. Grantham J.J., and Winklhofer F. Brenner & Rector's the kidney. 6th edition (2000), W.B. Saunders Company, Philadelphia
16. Roubidoux M.A. MR imaging of hemorrhage and iron deposition in the kidney. Radiographics 14 5 (1994) 1033-1044
17. Israel G.M., Hindman N., and Bosniak M.A. Evaluation of cystic renal masses: comparison of CT and MR imaging by using the Bosniak classification system. Radiology 231 2 (2004) 365-371
18. Israel G.M., and Bosniak M.A. Calcification in cystic renal masses: is it important in diagnosis?. Radiology 226 1 (2003) 47-52
19. Maki D.D., Birnbaum B.A., Chakraborty D.P., et al. Renal cyst pseudoenhancement: beam-hardening effects on CT numbers. Radiology 213 2 (1999) 468-472
20. Abdulla C., Kalra M.K., Saini S., et al. Pseudoenhancement of simulated renal cysts in a phantom using different multidetector CT scanners. AJR Am J Roentgenol 179 6 (2002) 1473-1476
21. Bosniak M.A. Difficulties in classifying cystic lesions of the kidney. Urol Radiol 13 2 (1991) 91-93
22. Israel G.M., and Bosniak M.A. Follow-up CT of moderately complex cystic lesions of the kidney (Bosniak category IIF). AJR Am J Roentgenol 181 3 (2003) 627-633
23. Guinan P., Sobin L.H., Algaba F., et al. TNM staging of renal cell carcinoma: Workgroup No. 3. Union International Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer 80 5 (1997) 992-993
24. Choyke P.L., Walther M.M., Wagner J.R., et al. Renal cancer: preoperative evaluation with dual-phase three-dimensional MR angiography. Radiology 205 3 (1997) 767-771
25. Dunnick N.R., and Korobkin M. Imaging of adrenal incidentalomas: current status. AJR Am J Roentgenol 179 3 (2002) 559-568
26. Korobkin M., Giordano T.J., Brodeur F.J., et al. Adrenal adenomas: relationship between histologic lipid and CT and MR findings. Radiology 200 3 (1996) 743-747
27. Hood M.N., Ho V.B., Smirniotopoulos J.G., et al. Chemical shift: the artifact and clinical tool revisited. Radiographics 19 2 (1999) 357-371
28. Israel G.M., Korobkin M., Wang C., et al. Comparison of unenhanced CT and chemical shift MRI in evaluating lipid-rich adrenal adenomas. AJR Am J Roentgenol 183 1 (2004) 215-219
29. Elsayes K.M., Narra V.R., Leyendecker J.R., et al. MRI of adrenal and extraadrenal pheochromocytoma. AJR Am J Roentgenol 184 3 (2005) 860-867
30. Kawashima A., Glockner J.F., and King Jr. B.F. CT urography and MR urography. Radiol Clin North Am 41 5 (2003) 945-961
31. Nolte-Ernsting C.C., Staatz G., Tacke J., et al. MR urography today. Abdom Imaging 28 2 (2003) 191-209
32. Tekes A., Kamel I., Imam K., et al. Dynamic MRI of bladder cancer: evaluation of staging accuracy. AJR Am J Roentgenol 184 1 (2005) 121-127
33. Claus F.G., Hricak H., and Hattery R.R. Pretreatment evaluation of prostate cancer: role of MR imaging and 1H MR spectroscopy. Radiographics 24 Suppl 1 (2004) S167-S180
34. Rajesh A., and Coakley F.V. MR imaging and MR spectroscopic imaging of prostate cancer. Magn Reson Imaging Clin N Am 12 3 (2004) 557-579 vii